Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Cash & Current Investments (2016 - 2026)

Metlife's Cash & Current Investments history spans 18 years, with the latest figure at $16.1 billion for Q1 2026.

  • Quarterly Cash & Current Investments fell 39.9% to $16.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.1 billion through Mar 2026, down 39.9% year-over-year, with the annual reading at $25.6 billion for FY2025, 50.29% up from the prior year.
  • Cash & Current Investments came in at $16.1 billion for Q1 2026, down from $25.6 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $27.5 billion in Q3 2022 to a low of $6.2 billion in Q4 2022.
  • The 5-year median for Cash & Current Investments is $17.1 billion (2025), against an average of $19.3 billion.
  • Year-over-year, Cash & Current Investments tumbled 49.75% in 2023 and then soared 88.13% in 2024.
  • Metlife's Cash & Current Investments stood at $6.2 billion in 2022, then soared by 45.64% to $9.1 billion in 2023, then skyrocketed by 88.13% to $17.1 billion in 2024, then skyrocketed by 50.29% to $25.6 billion in 2025, then tumbled by 37.0% to $16.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Cash & Current Investments are $16.1 billion (Q1 2026), $25.6 billion (Q4 2025), and $26.2 billion (Q3 2025).